| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |